Gastroenterology Search
Gastroenterology Gastroenterology
nonalcoholic%20fatty%20liver%20disease
NONALCOHOLIC FATTY LIVER DISEASE

Nonalcoholic fatty liver disease is having excessive hepatic fat (in the form of triglycerides) accumulation not due to excessive alcohol consumption or other secondary causes.

It is considered as a hepatic manifestation of metabolic syndrome.

Progression of nonalcoholic fatty liver disease is variable.

Nonalcoholic Fatty Liver Disease Drug Information

Drug Information
Essentiale Forte N
phospholipids

Indication: Nutritional support in the management of damaged liver due to chronic liver disease, liver cirrhosis, fatty li...

Shine Hepavite
calcium pantothenate + cyanocobalamin + nicotinami...

Indication: Adjuvant treatment of chronic liver disease, liver cirrhosis, fatty liver & intoxication by hepatotoxic su...

Shine Hepavite Forte
calcium pantothenate + nicotinamide + pyridoxine h...

Indication: Adjuvant treatment of chronic liver diseases, liver cirrhosis, fatty liver & intoxication by hepatotoxic s...

Simepar
calcium pantothenate + nicotinamide + silymarin + ...

Indication: Toxic & inflammatory liver disorders. Adjuvant in chronic liver disease.

Livolin Forte
nicotinamide + phospholipids + vitamin B1 + vitami...
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
What COVID-19 means for IBD care
Pearl Toh, 3 days ago
Updates from the SECURE-IBD* registry reveal that treatment with thiopurine, either alone or in combination with tumour necrosis factor inhibitors (TNFis), for inflammatory bowel disease (IBD) was associated with a greater risk of severe COVID-19 compared with TNFis monotherapy.